−0.060CAD
−1.87 MCAD
488.30 KCAD
6.33 M
About TRIPSITTER CLINIC LTD.
Sector
Industry
CEO
John Huber
Website
Headquarters
Toronto
FIGI
BBG013SVTYF1
TripSitter Clinic Ltd. provides on-line medical services. Its mobile-first webapp acts as virtual clinic, connecting patients with licensed medical practitioners. The company operates as a SaaS platform, functioning as the intermediary between patient and practitioner. TripSitter Clinic was founded on January 19, 2021 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KETA is 0.040 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange TRIPSITTER CLINIC LTD. stocks are traded under the ticker KETA.
KETA stock is 0% volatile and has beta coefficient of −1.87. Check out the list of the most volatile stocks — is TRIPSITTER CLINIC LTD. there?
Yes, you can track TRIPSITTER CLINIC LTD. financials in yearly and quarterly reports right on TradingView.
KETA net income for the last quarter is −83.64 K CAD, while the quarter before that showed −14.37 K CAD of net income which accounts for −482.09% change. Track more TRIPSITTER CLINIC LTD. financial stats to get the full picture.
No, KETA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KETA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRIPSITTER CLINIC LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TRIPSITTER CLINIC LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TRIPSITTER CLINIC LTD. stock shows the neutral signal. See more of TRIPSITTER CLINIC LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRIPSITTER CLINIC LTD. EBITDA is −454.42 K CAD, and current EBITDA margin is −381.04%. See more stats in TRIPSITTER CLINIC LTD. financial statements.